Addition of Ezetimibe to Intensive Lipid-Lowering Therapy Is Associated With a Lower Incidence of Heart Failure in Patients With Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Addition of Ezetimibe to Intensive Lipid-Lowering Therapy Is Associated With a Lower Incidence of Heart Failure in Patients With Acute Coronary Syndrome

Published:2024-09-11 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Yoshikawa Masafumi¹,Honda Atsushi²,Arashi Hiroyuki¹³,Shibahashi Eiji¹,Otsuki Hisao¹,Kawada-Watanabe Erisa¹,Ogawa Hiroshi¹,Yamaguchi Junichi¹,Hagiwara Nobuhisa¹

Affiliation:

1. Department of Cardiology, Tokyo Women’s Medical University

2. Department of Cardiology, Tokyo Women’s Medical University Yachiyo Medical Center

3. Department of Cardiovascular Medicine, Tokyo Women’s Medical University Adachi Medical Center

Publisher

Japanese Circulation Society

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-24-0536/_pdf

Reference23 articles.

1. 1. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41: 111–188, doi:10.1093/eurheartj/ehz455.

2. 2. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495–1504, doi:10.1056/NEJMoa040583.

3. 3. Krychtiuk KA, Ahrens I, Drexel H, Halvorsen S, Hassager C, Huber K, et al. Acute LDL-C reduction post ACS: Strike early and strike strong: From evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Acute Cardiovasc Care 2022; 11: 939–949, doi:10.1093/ehjacc/zuac123.

4. 4. Scirica BM, Morrow DA, Cannon CP, Ray KK, Sabatine MS, Jarolim P, et al. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. J Am Coll Cardiol 2006; 47: 2326–2331, doi:10.1016/j.jacc.2006.03.034.

5. 5. Bugiardini R, Yoon J, Mendieta G, Kedev S, Zdravkovic M, Vasiljevic Z, et al. Reduced heart failure and mortality in patients receiving statin therapy before initial acute coronary syndrome. J Am Coll Cardiol 2022; 79: 2021–2033, doi:10.1016/j.jacc.2022.03.354.